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Abstract
Background: The aim of the current study was to assess the reliability and validity of the Greek translation of the
Short Anxiety Screening Test (SAST), for use in primary care settings. The scale consists of 10 items and is a brief
clinician rating scale for the detection of anxiety disorder in older people, particularly, in the presence of
depression.
Methods: The study was performed in two rural primary care settings in Crete. The sample consisted of 99 older
(76 ± 6.3 years old) people, who fulfilled the participating criteria. The translation and cultural adaptation of the
questionnaire was performed according to international standards. Internal consistency using the Cronbach a
coefficient and test-retest reliability using the intraclass correlation coefficient (ICC) was used to assess the reliability
of the tool. An exploratory factor analysis using Varimax with Kaiser normalisation (rotation method) was used to
examine the structure of the instrument, and for the correlation of the items interitem correlation matrix was
applied and assessed with Cronbach a.
Results: Translation and backtranslation did not reveal any specific problems. The psychometric properties of the
Greek version of the SAST scale in primary care were good. Internal consistency of the instrument was good, the
Cronbach a was found to be 0.763 (P < 0.001) and ICC (95% CI) for reproducibility was found to be 0.763 (0.686 to
0.827). Factor analysis revealed three factors with eigenvalues >1.0 accounting for 60% of variance, while the
Cronbach a was >0.7 for every item.
Conclusions: The Greek translation of the SAST questionnaire is comparable with that of the original version in
terms of reliability, and can be used in primary healthcare research. Its use in clinical practice should be primarily as
a screening tool only at this stage, with a follow-up consisting of a detailed interview with the patient, in order to
confirm the diagnosis.
Background
Anxiety remains one of the most common mental pro-
blems that older individuals experience [1,2], although
anxiety disorders in older people appear to remain
underdiagnosed and undertreated by primary care prac-
titioners [3,4]. The development of accurate diagnostic
instruments for use in primary healthcare (PHC)
remains a challenge, especially in settings with limited
resources and research capacity such as Greece [5-7].
The necessity of the development for this kind of instru-
ments for primary care settings arises from a recent
review which declares that the longstanding dominance
of medical perspectives in Greek health policy has been
paving the way towards vertical integration, pushing
aside any discussions about horizontal or comprehensive
integration of care [8]. Furthermore, the use of recog-
nised tools constitutes a necessity for the international
community, not only for epidemiologic comparisons but
also for quality of life improvement [9-13].
Several instruments have been translated into Greek
for the identification of depression [14-16] and for anxi-
ety disorders with self-rated instruments [17,18]. Anxi-
ety disorders among older people seem to constitute a
somewhat neglected subject in Greeceand the area
needs more attention [19,20], especially because doctors
have difficulties in diagnosing and managing anxiety
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(SAST) was developed to provide clinicians with a sim-
ple tool for detecting anxiety disorders in older people.
It was developed and standardised in 1999 by Sinoff et
al [24] and was considered appropriate for our study
purpose for the following reasons: it is short and easy to
apply in clinical settings and it is based on an inter-
viewer-assisted self-rating scale, rendering it practical for
use in everyday practice. According to the developers,
the instrument can accurately and reliably identify
symptoms of anxiety in older people even, and espe-
cially, in the presence of depression [24].
This article reports on the translation and validation
of the SAST questionnaire and discusses several possibi-
lities for implementation in the Greek primary health-
care setting.
Methods
Questionnaire
The SAST fulfils the criteria defined by the Diagnostic
and Statistical Manual of Mental Disorders, fourth edi-
tion (DSM-IV) and contains questions relating to
somatic symptoms, often the manifestation of anxiety
in older people [25]. It includes, among others, modifi-
cations of selected, commonly recurring questions as
found in other instruments. The scale consists of 10
items rated on a 4-point response scale ranging from 1
to 4 and generating scores between 10 and 40, with a
higher score equalling a higher degree of anxiety.
Responses include ‘rarely or never’, ‘sometimes’, ‘often’
and ‘always’ (see Additional file 1). SAST requires 10
to 15 min to administer and a total score is calculated
by the sum of the grades of all questions. A score of ≥
24 is the cut-off point for the diagnosis of anxiety,
while a score of 22 to 23 reflects borderline test
results.
Study population
In all, 99 consecutive patients attending 2 rural PHC
centres in Crete over a period of 2 months were
recruited. The study took place during the morning
shifts of two doctors. All participants agreed to complete
the questionnaire. Eligibility criteria included that parti-
cipants should be over 65 years old, should have given
their written consent, and were free of any cognitive
impairment according to the doctor’s records.
At 2 weeks later, the final 26 participating persons
from 1 PHC centre were selected to answer the ques-
tionnaire for a second time, and all of them agreed to
do so (retest response rate 100%). This period of time is
considered neither too long for a person’s mental status
t oh a v ec h a n g e d ,n o rt o os h o r tf r o mt h ef i r s ta p p l i c a -
tion. The size of the retest sample (n = 26) was suffi-
cient as suggested by Walter et al [26].
Translation
Based on procedures set by the Clinic of Social and
Family Medicine at the University of Crete, written per-
mission was obtained by the original developers and
also the copyright holder, to proceed with the transla-
tion and use of the tool for research purposes only. The
translation and cultural adaptation of SAST was per-
formed according to ‘The Minimal Translation Criteria’
[27]. Two independent bilingual physicians with
advanced levels of English language and mother tongue
of the Greek language translated the questionnaire into
Greek (forward translation). With the contribution of a
third reviewer, a reconciliation meeting was conducted
to develop a consensus version (reconciliation Greek
version). A psychologist, who was a native English
speaker and who was blinded to the original version,
retranslated the reconciliated Greek version into the
source language (backtranslation). The backtranslation
was sent to the developer of the original questionnaire
for comparison and his suggestions were incorporated,
thus formulating the revised Greek version of the SAST.
A cognitive debriefing process was used for the cul-
tural adaptation of the questionnaire as the last step of
the translation procedure [27]. This process was carried
out in order to identify any areas presenting linguistic
problems and to assess the patient’s level of understand-
ing with the purpose of revealing inappropriate items
and translation alternatives. As part of this process, the
questionnaire was administered to five attendants of a
PHC centre, and comments made by them were dis-
cussed in a debriefing summary and a final debriefing
decision grid was sent to the developer for comments;
this led to the final Greek version of the SAST. Figure 1
demonstrates the flow of the translation process.
Statistical analysis
Descriptive characteristics (including means, SDs, fre-
quencies and percentages) were calculated for the socio-
demographic variables. For categorical data we used
Pearson r, and for dichotomous discrete data the c
2 sta-
tistic. For categorical data with more than two terms we
used one-way analysis of variance (ANOVA) and in
cases of statistical significance, a post hoc (Student-New-
man-Keuls) analysis was performed.
Reliability
Internal consistency and reproducibility were measured
as part of the reliability testing of the translated tool
[28]. Internal consistency was determined by the use of
Cronbach a, requiring a minimum value of 0.70 for
group and 0.90 for individual comparisons [29,30].
Reproducibility (test- retest reliability) is a measure of
strength of association for determining stability of the
questionnaire’s results over time because it corrects for
lack of independence between measurement intervals
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intraclass correlation coefficient (ICC) [31]. The test-ret-
est reliability coefficient, sometimes called the stability
coefficient, tests the assumption that when a characteris-
tic is measured twice, both measures must lead to com-
parable results. However, test-retest reliability is only a
valid indicator of the reliability of an instrument if the
characteristic under study has not changed in the inter-
val between testing and retesting. This means either a
relatively stable characteristic (such as intelligence, per-
sonality, socioeconomic status) or a short time interval.
A short time interval between test administrations, how-
ever, may produce biased (inflated) reliability coeffi-
cients, due to the effect of memory [32].
Validation
A factor analysis was performed in order to determine
the structure of the questionnaire and to highlight how
the individual items grouped together [33,34]. The fac-
tor structure was studied by principal component analy-
sis using Varimax with Kaiser normalisation as rotation
method. A factor was considered important if its eigen-
values exceeded 1.0 [35].
Ethics
The scientific committee of the University Hospital of
Heraklion, Crete approved this study (protocol no.
12521/25/10/2006). All participants involved in the cul-
tural adaptation and reproducibility (test-retest reliabil-
ity) procedure were informed about the scope and the
purpose of the study, and provided written consent.
Results
Study population
The study involved 99 participating individuals, with a
mean age of 76 years (SD ± 6.36 years), consisting of 56
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Figure 1 Graphic representation of the stages of the translation process.
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Page 3 of 8women (56.6%) and 43 men (43.4%). The age distribu-
tion was equable, since 46 persons (46.5%) were within
t h ea g er a n g eo f6 5t o7 4y e a r sa n d5 3p e r s o n s( 5 3 . 5 % )
were >75 years old (Table 1). There was no statistically
significant difference when we compared the health cen-
tres and sex (c
2 = 0.152, degrees of freedom (df) = 1, P
= 0.697) or the health centres and the age distribution
(c
2 = 0.567, df = 1, P = 0.451) (Table 2).
When the total scores for SAST were examined, the
test results proved negative for 58.6% (N = 58), border-
line for 12.1% (N = 12), and positive for 29.3% (N = 29)
(Table 3).
The mean score for older people with negative results
was 17.6 (SD ± 2.28), whilst for those with a positive
result the mean score was 28.5 (SD ± 3.24). The applica-
tion of ANOVA identified a statistically significant dif-
ference between the scores (P < 0.0001, F = 188,281)
(Table 3). Post hoc analysis showed that the SAST score
differed at the significance level P < 0.0001.
The total mean score of the SAST for the study popu-
lation as a whole was 21.3 (SD ± 5.5; min 12, max 36).
The mean score for women was 22.8 (SD ± 5.8) and for
men 19.5 (SD ± 4.3). With the use of t test for indepen-
dent samples, this difference was found to be statistically
significant (t = 3.105, df = 97, P = 0.002). In contrast,
there was no statistically significant difference when we
compared the mean scores across age distribution (t =
0.837, df = 97, P = 0.404) or for the individual health
centres (t = -0.382, df = 97, P = 0.704) (Table 4).
Translation
The translation procedures did not reveal any specific
problems. The developers of the SAST made some com-
ments on three of the backtranslated questions where
minor issues were identified. These concerned the inter-
pretation of the word ‘irritable’ (question 8), the differ-
entiation of the expression ‘back pain’ (question 6) and
the interpretation of the word ‘palpitations’ (question 7),
emphasising the somatic complaints of older people.
These comments were taken into account when finalis-
ing the Greek reconciliated version of the SAST.
During cultural adaptation, the questionnaire was
found to be overall comprehensible and easy to under-
stand, according to comments from older people. The
only linguistic problem concerned question 8, where all
respondents proposed to change the Greek word for
‘irritable’ into a less obscure word that would be more
easily understood by the respondents. Their
Table 1 Demographic characteristics of the sample
Number, N Frequency, % Mean (± SD)
Sex:
Male 43 43.4% 76.5 (± 6.3)
Female 56 56.6% 75.6 (± 6.4)
Age distribution:
65 to 74 46 46.5%
≥ 75 53 53.5%
Health centre:
Spili 62 62.6%
Anogia 37 37.4%
Table 2 Comparison of the parameters of the
study sample
Health centre Total,
N (%)
Pearson
c
2
Anogia,
N (%)
Spili,
N (%)
Sex:
Female 20 (54.1%) 36 (58.1%) 56 (56.6%) c
2 = 0.152,
df = 1, P = 0.697
Male 17 (45.9%) 26 (41.9%) 43 (43.4%)
Age
distribution:
65 to 74 19 (41.3%) 27 (58.7%) 46 (46.5%) c
2 = 0.567,
df = 1, P = 0.451
≥ 75 18 (34.0%) 35 (66.0%) 53 (53.5%)
Total N (%) 37 (100.0%) 62 (100.0%) 99
(100.0%)
c
2 = -0.382,
df = 97, P=0 . 7 0 4
Table 3 Comparison of the Short Anxiety Screening Test
(SAST) results (analysis of variance (ANOVA))
Results N
(%)
Mean (± SD) Minimum Maximum ANOVA
Negative test 58
(58.6%)
17.6 (± 2.3) 12 21
F=
188,281,
df = 2, P
< 0.0001
Borderline
test
12
(12.1%)
22.3 (± 0.5) 22 23
Positive test 29
(29.3%)
28.5 (± 3.3) 24 36
Total 99
(100%)
21.3 (± 5.5) 12 36
Table 4 Comparison of the Short Anxiety Screening Test
(SAST) results for sex, age distribution and health centres
Frequency, N SAST score,
mean (± SD)
t Test
Sex:
Male 56 22.8 (± 5.8) t = 3.105,
df = 97, P =0 . 0 0 2
Female 43 19.5 (± 4.3)
Age distribution:
65 to 74 46 21.8 (± 5.5) t = 0.837,
df = 97, P = 0.404
≥ 75 53 20.9 (± 5.5)
Health centre:
Spili 37 21.1 (± 6.1) t = 0.382,
df = 97, P = 0.704
Anogia 62 21.5 (± 5.1)
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the final Greek translation of the questionnaire.
Feedback from the doctors demonstrated that the
questionnaire was comprehensible, easy and quick
(approximately 10 min) to use, and that it could be used
in everyday clinical practice for primary assessment,
while interviewing the patients regarding mental health
issues.
Reliability and validity
The SAST questionnaire showed a very good overall
internal consistency (a value: 0.763, 95% CI 0.71 to
0.82, P < 0.001) for individual comparison. The overall
Cohen  coefficient for reproducibility (test-retest relia-
bility) was ‘very good’ (0.930, 95% CI 0.918 to 0.942, P <
0.0001) and ICC (95% CI) for reproducibility was found
to be 0.763 (95% CI 0.686 to 0.827) [25]. The Wilcoxon
s i g n e dr a n k st e s ts h o w e dt h a tt h e r ew a sn os t a t i s t i c a l l y
significant difference between the total of questions (z =
0.676, P = 0.499), as in the comparison for each ques-
tion separately between the two applications of ques-
tionnaire (N = 26), with values oscillated from z = 0.0
(P = 1.0) in question 3, to z = 1.134 (P = 0.257) in ques-
tion 9. The results are illustrated in Table 5.
Exploratory factor analysis indicated three factors with
eigenvalues over 1.0. Those factors were responsible for
60% of variance and rotation converged in three itera-
tions (Table 6). At the same time, for the control of
crosscorrelation of items among them using the interi-
tem correlation matrix method, analysis showed that all
questions correlated very well, as Cronbach a values
were all greater than 0.7 (Table 7).
The independent samples t test identified the SAST’s
ability to discriminate between older men and women,
with women scoring significantly higher. Higher levels
of anxiety in women have been reported in previous stu-
dies [1,2,36].
Discussion
Main findings
The current study suggests that the Greek version of the
SAST is suitable for use in the Greek primary healthcare
setting, demonstrating good internal consistency and
high test-retest reliability. The factor structure of the
Greek translation is similar to that reported in the lit-
erature [37]. The statistically significant difference
between the total scores for older people with positive
results, and for those with negative results (28,5 vs
17,6), offers further support for the validity of the
Table 5 Short Anxiety Screening Test (SAST)
reproducibility (test-retest reliability)
Question First application
(test), (N = 26),
mean ± SD
Second
application
(retest), (N = 26),
mean ± SD
z
a,
P value
Question 1 2.12 ± 0.816 2.15 ± 0.784 z = 1.000,
P = 0.317
Question 2 1.92 ± 0.977 1.96 ± 0.958 z = 1.000,
P = 0.317
Question 3 2.15 ± 0.543 2.15 ± 0.543 z = 0.000,
P = 1.00
Question 4 2.42 ± 0.758 2.38 ± 0.697 z = 0.577,
P = 0.564
Question 5 2.58 ± 0.857 2.62 ± 0.752 z = 0.577,
P = 0.564
Question 6 1.54 ± 0.859 1.58 ± 0.857 z = 1.000,
P = 0.317
Question 7 1.27 ± 0.533 1.31 ± 0.549 z = 1.000,
P = 0.317
Question 8 1.69 ± 0.838 1.62 ± 0.697 z = 1.000,
P = 0.317
Question 9 2.19 ± 1.167 2.31 ± 1.087 z = 1.134,
P = 0.257
Question 10 1.65 ± 0.797 1.58 ± 0.758 z = 0.632,
P = 0.527
Total 19.58 ± 3.489 19.69 ± 3.541 z = 0.676,
P = 0.499
aWilcoxon signed rank test.
Table 6 Factor analysis for the symptoms: rotated component matrix for three factors
Components Rotation sums of squared loadings
Variance of factor Eigenvalues Degree of
explanation, %
Cronbach a
Factor I (somatic symptoms
and autonomic arousal)
Item 6 0.676
2.307 23.074 0.699
Item 7 0.761
Item 9 0.611
Item 10 0.745
Factor II (symptoms of
tension and distress)
Item 1 0.809
1.837 18.374 0.642 Item 2 0.461
Item 8 0.838
Factor III (mental state
symptoms: fears and
concerns)
Item 3 0.430
1.818 18.183 0.618 Item 4 0.860
Item 5 0.810
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was able to discriminate between male and female
patients. This result sues for the original study for the
development of the SAST (25.3 vs 20.1) [24].
Implications for practice
Accurate screening for anxiety symptoms in older popu-
lations is a crucial first step in identifying patients in
need of further diagnostic procedures and treatment
[38]. Although the use of self-report scales is frequent in
psychiatric research, saving time for the clinician, it is
also well known that these types of scales depend heav-
ily on the cooperation and reading ability of the patient
[16-18]. Our criteria was partially based on this fact
when we selected the SAST, because it is an inter-
viewer-assisted observational instrument, developed spe-
cifically for the detection of anxiety in older people,
even and especially in the presence of depression,
according to the developers of the original SAST ques-
tionnaire [24]. In addition, its brevity as a screening
instrument (10 questions), renders it useful in everyday
clinical practice and especially by primary care
physicians.
Although a substantial amount of literature has
addressed the overlap between depression and medical
conditions [39], the same attention has not been given
to anxiety disorders. Clinical ratings of anxiety severity
also appear useful for older adults, although differentia-
tion of anxiety and depression continues to be an issue
of concern with regard to interpretation of scores [40].
Anxiety is one of the most common psychiatric diag-
noses in primary care populations [41]. Thus, screening
questionnaires are actually evaluated for their ability to
detect unrecognised anxiety symptoms and disease.
They are also useful for the follow-up assessment
though not for an accurate diagnosis. These instruments
are of particular value in primary care settings because
it is clear that primary care providers fail to diagnose
and treat as many as 35% to 50% of patients with anxi-
ety disorders [42-44].
The findings from our study imply that the Greek
translation of the SAST is a useful and reliable instru-
ment for primarily detecting anxiety disorders in older
patients attending Greek primary healthcare settings.
The instrument is quick and easy for clinicians to use,
and is easily understood by the attending patients.
Limitations and concerns
The current study is not without certain limitations.
Firstly, the study presents preliminary data and in
addition the study sample was small and test-retest
data was only available for 26 subjects. Full-scale vali-
dation requires the application of the scale in larger
samples, and with the application of more sophisti-
cated methodology, such as the use of borderline cases
and comparison with psychiatric interview. Further
testing of the SAST on a sample of psychogeriatric
patients, as well as patients in long-term care facilities,
those with dementia of mild severity, and also older
people with general medical conditions commonly
associated with anxiety symptoms, is required before
the instrument can be more generally recommended
for clinical practice.
We conducted a factor analysis to explore the structure
of the Greek translation of the SAST, which was not
applied in the original study of the SAST developers.
This enabled us to identify the separate factors contribut-
ing to the composition of the questionnaire. The use of
standardised instruments is important for the develop-
ment of research capacity in PHC. As such, various stu-
dies have explored the use of questionnaires for
measuring the frequency of health problems in primary
care, and the impact of various physical conditions on
the quality of life of Greek patients [45,46]. It is antici-
pated that the translated and validated version of SAST
could be used as a practical instrument for use by
Table 7 Short Anxiety Screening Test (SAST) interitem correlation matrix
Question
1
Question
2
Question
3
Question
4
Question
5
Question
6
Question
7
Question
8
Question
9
Question
10
Cronbach
a if item
deleted
Question 1 1.000 0.291 0.247 0.025 0.132 0.280 0.206 0.485 0.109 0.124 0.752
Question 2 0.291 1.000 0.437 0.117 0.350 0.242 0.318 0.291 0.247 0.290 0.732
Question 3 0.247 0.437 1.000 0.319 0.280 0.246 0.401 0.274 0.199 0.338 0.729
Question 4 0.025 0.117 0.319 1.000 0.511 0.053 0.075 0.017 0.163 -0.011 0.770
Question 5 0.132 0.350 0.280 0.511 1.000 0.138 0.196 0.145 0.416 0.244 0.736
Question 6 0.280 0.242 0.246 0.053 0.138 1.000 0.456 0.295 0.374 0.344 0.737
Question 7 0.206 0.318 0.401 0.075 0.196 0.456 1.000 0.078 0.294 0.414 0.736
Question 8 0.485 0.291 0.274 0.017 0.145 0.295 0.078 1.000 0.091 0.158 0.753
Question 9 0.109 0.247 0.199 0.163 0.416 0.374 0.294 0.091 1.000 0.338 0.741
Question 10 0.124 0.290 0.338 -0.011 0.244 0.344 0.414 0.158 0.338 1.000 0.742
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toms of anxiety, in addition to its use as a research tool.
However, we recommend that the application of the
current Greek translation of SAST is restricted to its
use as a screening tool, within primary care settings.
Thus the SAST could be used to obtain preliminary
information with regard to anxiety symptoms, which
would then need to be followed-up by a detailed inter-
view with the patient, for a diagnosis to be confirmed.
This Greek version of SAST could facilitate clinical
observational research in primary care and general prac-
tice, contributing to the formulation of diagnostic
nomograms and particularly to the pretest probability.
Furthermore, it is proposed that the Greek SAST could
be used in routine care simultaneously with the Greek
version of the World Health Organization WHO-5 well-
being index. The WHO-5 is a five-item measure of well-
being, widely used as a depression screener, with an
established clinical cut-off point. The use of the two of
these instruments together over time may provide useful
information with regard to patients scoring below the
WHO-5 cut-off point, and demonstrating anxiety as
identified by SAST.
Conclusions
The Greek translated SAST questionnaire appears to be
a reliable and valid tool for screening for anxiety symp-
toms in older people. Due to its brevity and ease of
administration, the SAST could be a useful instrument
for routine practical use within Greek primary care
settings.
Additional file 1: Short Anxiety Screening Test. The Greek version of
the questionnaire.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1744-859X-9-1-
S1.DOC]
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